Quick Answer
NovaBridge Biosciences reported Net Income of -$22.23 million for fiscal year 2024.
NovaBridge Biosciences Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$22.23M | +89.3% |
| 2023 | -$207.73M | +44.0% |
| 2022 | -$371.05M | +84.1% |
| 2021 | -$2.33B | -595.1% |
| 2020 | $470.92M | +132.4% |
| 2019 | -$1.45B | -260.4% |
| 2018 | -$402.83M | -35.1% |
| 2017 | -$298.24M | — |
- NovaBridge Biosciences showed an increase of +89.3% in Net Income compared to the prior fiscal year.
- Over the 2017–2024 period, NovaBridge Biosciences’s net income has grown by 92.5% (from -$298.24 million to -$22.23 million).
- The most recent figure is from NovaBridge Biosciences’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: